 |
| |
 |
| |
 |
| |
 |
| |
 |
| _____________________________________________________________________________________________________________________ © 2005-11 All Rights Reserved. NOD Pharmaceuticals, Inc. |
Shanghai, Jan. 31, 2007 /For Immediate Release/ -- NOD Pharmaceuticals today announced
appointment of Drs. Leon Chen and Andrew Lo as Directors.
"Leon and Andrew are seasoned in the life science industry and can be of great help to the
Company's business", William Lee, CEO of NOD Pharmaceuticals explains. "Now, at Board level,
we have a talented, experienced and balanced team."
NOD Pharmaceuticals is an innovative biotechnology company focusing on delivery of
macromolecular drugs such as insulin. NOD Pharmaceuticals uses proprietary nano-particle oral
delivery or NOD technology to develop oral formulations of biopharmaceutical products.
SOURCE NOD Pharmaceuticals, Inc.
William Lee, Ph.D, CEO of NOD Pharmaceuticals, Inc., +1-858-717-0332
URL http://www.nodpharm.com
Email info@nodpharm.com
appointment of Drs. Leon Chen and Andrew Lo as Directors.
"Leon and Andrew are seasoned in the life science industry and can be of great help to the
Company's business", William Lee, CEO of NOD Pharmaceuticals explains. "Now, at Board level,
we have a talented, experienced and balanced team."
NOD Pharmaceuticals is an innovative biotechnology company focusing on delivery of
macromolecular drugs such as insulin. NOD Pharmaceuticals uses proprietary nano-particle oral
delivery or NOD technology to develop oral formulations of biopharmaceutical products.
SOURCE NOD Pharmaceuticals, Inc.
William Lee, Ph.D, CEO of NOD Pharmaceuticals, Inc., +1-858-717-0332
URL http://www.nodpharm.com
Email info@nodpharm.com
Press Release
| Chen and Lo Are Appointed as Directors of NOD Pharmaceuticals |
 |  |  |
-Innovation Delivered